Breaking News Instant updates and real-time market news.

EMR

Emerson

$71.60

0.13 (0.18%)

, TDG

TransDigm

$368.89

-0.89 (-0.24%)

20:25
08/06/18
08/06
20:25
08/06/18
20:25

Notable companies reporting before tomorrow's open

Notable companies reporting before tomorrow's open, with earnings consensus, include Emerson Electric (EMR), consensus 86c... TransDigm (TDG), consensus $4.07... Expeditors (EXPD), consensus 78c... Discovery (DISCA), consensus 86c... DENTSPLY SIRONA (XRAY), consensus 59c... Aramark (ARMK), consensus 48c... Office Depot (ODP), consensus 4c... Dean Foods (DF), consensus 16c.

EMR

Emerson

$71.60

0.13 (0.18%)

TDG

TransDigm

$368.89

-0.89 (-0.24%)

EXPD

Expeditors

$77.48

0.91 (1.19%)

DISCA

Discovery

$26.92

-0.14 (-0.52%)

XRAY

Dentsply Sirona

$48.41

0.69 (1.45%)

ARMK

Aramark

$38.25

-0.07 (-0.18%)

ODP

Office Depot

$2.51

0.035 (1.41%)

DF

Dean Foods

$9.45

-0.245 (-2.53%)

  • 07

    Aug

  • 07

    Aug

  • 07

    Aug

  • 07

    Aug

  • 07

    Aug

  • 07

    Aug

  • 07

    Aug

  • 09

    Aug

  • 27

    Sep

  • 06

    Nov

EMR Emerson
$71.60

0.13 (0.18%)

07/12/18
DBAB
07/12/18
UPGRADE
Target $81
DBAB
Buy
Emerson resumed with a Buy from Hold at Deutsche Bank
Deutsche Bank analyst Nicole DeBlase resumed coverage of Emerson with a Buy rating and $81 price target, an upgrade from her firm's prior Hold rating. The analyst prefers "late-cycle CapEx-driven exposure" given "strong prospects" for continued capital spending growth over the next several years.
04/24/18
BREN
04/24/18
UPGRADE
BREN
Hold
Emerson upgraded to Hold from Sell at Berenberg
02/15/18
LEHM
02/15/18
INITIATION
Target $80
LEHM
Overweight
Emerson initiated with an Overweight at Barclays
Barclays analyst Julian Mitchell started Emerson Electric with an Overweight rating and $80 price target. The analyst initiated 24 Multi-Industry companies with a Neutral sector view.
04/24/18
04/24/18
UPGRADE
Target $69

Hold
Emerson upgraded to Hold, valuation 'fair,' says Berenberg
As previously reported, Berenberg upgraded Emerson to Hold from Sell and raised its price target to $69. Analyst Simon Toennessen views valuation as "fair" and is more positive on the prospects for Commercial & Residential Solutions in Asia and larger projects in Automation Solutions to support growth against tough comps from US shale.
TDG TransDigm
$368.89

-0.89 (-0.24%)

06/29/18
ADAM
06/29/18
NO CHANGE
Target $375
ADAM
Buy
TransDigm price target raised to $375 from $350 at Canaccord
Canaccord analyst Ken Herbert raised his price target on TransDigm (TDG) to $375 from $350 following its analyst day. The meeting focused on the organic growth outlook by market, an update to longer-term assumptions, the M&A process and pipeline, and the potential risks around Boeing (BA) entering the services market. Herbert said the company is not looking at any major changes despite a new CEO, but he believes that will be comforting to investors and should be viewed as a positive. He reiterated his Buy rating on TransDigm shares.
06/29/18
FBCO
06/29/18
NO CHANGE
Target $400
FBCO
Outperform
TransDigm price target raised to $400 from $350 at Credit Suisse
Credit Suisse analyst Robert Spingarn reiterated an Outperform rating on TransDigm (TDG) and raised his price target to $400 after attending the company's biennial Investor Day yesterday in New York City, telling investors in a research note that the turnout was "standing room only" and Executive Chairman Nick Howley sent a "bullish" message. At the meeting, new CEO Kevin Stein reiterated that he intends to follow in Howley's footsteps, maintaining TransDigm's outsized growth rates and M&A strategy, and both Stein and Howley "offered a high degree of confidence" that Boeing's (BA) PFS 2.0 will not imapct its financial performance.
07/11/18
COWN
07/11/18
UPGRADE
COWN
Outperform
TransDigm upgraded to Outperform from Market Perform at Cowen
07/11/18
07/11/18
UPGRADE
Target $408

Outperform
TransDigm upgraded to Outperform on reduced risks at Cowen
As previously reported, Cowen upgraded TransDigm (TDG) to Outperform from Market Perform with a $408 price target telling investors fundamental threats to TransDigm's aftermarket/M&A playbook are abating. Analyst Gautam Khanna said contract talks between TransDigm and Boeing (BA) are close to being agreed upon with no major threats to TransDigm, and concerns regarding deal economics appear to be misplaced. Further, the Department of Defense procurement rule as of July 1 may actually provide TransDigm with more pricing power versus the old policy, Khanna wrote in a note to investors. The analyst adds, the Department of Defense inquiry is also nearing completion with any fines likely to be minimal, end markets are improving, and the company has $2.3B available for M&A or dividends.
EXPD Expeditors
$77.48

0.91 (1.19%)

11/13/17
GSCO
11/13/17
INITIATION
Target $59
GSCO
Neutral
Expeditors initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Matt Reustle initiated Expeditors of Washington with a Neutral rating and $59 price target. The analyst started the Rails sector with a Cautious coverage view and the Airfreight/Logistics sector with an Attractive coverage view.
11/08/17
UBSW
11/08/17
NO CHANGE
Target $56
UBSW
Sell
Expeditors earnings growth likely to remain muted, says UBS
UBS analyst Thomas Wadewitz noted Expeditors reported better than expected Q3 results on the strength of airfreight tonnage growth. He said it helped drive solid earnings growth, but gross margins continued to be pressured. The analyst believes earnings growth is likely to remain muted due to the potential cooling in air tons growth and pressure on air and ocean yields. Wadewitz maintained his Sell rating but raised his price target to $56 from $48 on Expeditors shares.
DISCA Discovery
$26.92

-0.14 (-0.52%)

07/03/18
IMPC
07/03/18
NO CHANGE
Target $32
IMPC
Outperform
Discovery will not bid for Fox regional sports networks, says Imperial Capital
Imperial Capital analyst David Miller says Discovery (DISCA) is seeing "unnecessary selling pressure" on media reports that the company is a potential bidder for the Fox regional sports networks, which Disney (DIS), through its pending acquisition of the entertainment assets of 21st Century Fox (FOXA), will have to divest, as per the Department of Justice decree. The analyst believes potential bidders for these assets will include Charter (CHTR), Liberty Media (LMCA), Altice (ATUS), and various private equity entities, but not Discovery. Discovery is fully occupied with the integration of Scripps Networks, the sale of its headquarters building in Bethesda, Maryland, as well as ratings issues at its core Discovery Channel, Miller tells investors in a research note. Further, he notes that Discovery already pledged $2B in additional sports rights to broadcast various PGA Tour events via its networks outside of the U.S. through 2030. As such, the analyst thinks the recent pullback has created an "attractive opportunity to either establish new positions, or for existing holders to lower their bases." Miller keeps an Outperform rating on Discovery with a $32 price target.
07/19/18
07/19/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Square (SQ) upgraded to Outperform from Neutral at Credit Suisse WITH analyst Paul Condra saying he believes its growing product eco-system is increasing its ability to penetrate larger merchants, positive data points on Cash-App adoption validate Square's two-sided platform strategy to grow both merchant and consumer use-cases, and growth investing should support strong revenue trends driving upside to revenue forecasts in the out-years. 2. Discovery (DISCA) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Drew Borst saying Discovery's acquisition of Scripps creates "meaningful" cost and revenue synergy opportunities. 3. Grainger (GWW) upgraded to Neutral from Sell at UBS with analyst Steven Winoker saying the company's strategic initiatives, including its pricing reset and e-commerce platform development, reposition it to gain market share through 2019. 4. Hilton (HLT) upgraded to Buy from Hold at Berenberg. 5. United Continental (UAL) upgraded to Outperform from Neutral at Macquarie. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/19/18
GSCO
07/19/18
UPGRADE
Target $33
GSCO
Conviction Buy
Discovery upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman Sachs analyst Drew Borst added Discovery to his firm's Americas Conviction List, while maintaining a Buy rating on the shares, with 24% upside to his $33 12-month price target. Discovery's acquisition of Scripps creates "meaningful" cost and revenue synergy opportunities, Borst tells investors in a research note. The analyst views Discovery's carriage on Sling TV, a successful advertising upfront, and positive earnings revisions as near-term catalysts for the shares.
07/10/18
FBCO
07/10/18
INITIATION
Target $30
FBCO
Neutral
Discovery initiated with a Neutral at Credit Suisse
Credit Suisse analyst Douglas Mitchelson initiated Discovery with a Neutral rating and a price target of $30. The analyst notes that while the company has "excellent brands and management", its scale is lacking to compete against against large distributors as its pay TV profits pale compared to streaming. The analyst adds that it is unlikely for potential acquirers to appear and pursue Discovery's non-fiction programming assets.
XRAY Dentsply Sirona
$48.41

0.69 (1.45%)

07/20/18
MSCO
07/20/18
NO CHANGE
Target $122
MSCO
Overweight
Danaher creating value with Dental spin off, says Morgan Stanley
Morgan Stanley analyst Steve Beuchaw believes Danaher (DHR) is creating value with its Dental spin off, contending that the move will likely create a "RemainCo" with a faster growing top-line and higher margins, which should support multiple expansion. Investor feedback so far applies a Dentsply Sirona (XRAY) EBITDA multiple on Dental and a Tools industry multiple on the RemainCo, but Beuchaw believes this too conservative. Using his own free cash flow valuation, he could see the RemainCo plus Dental SpinCo being worth $120-$125 per share. Beuchaw raised his price target on Danaher to $122 from $120 and keeps an Overweight rating on the shares.
07/18/18
GSCO
07/18/18
NO CHANGE
Target $43
GSCO
Sell
Dentsply Sirona and Patterson Companies guidance at risk, says Goldman Sachs
Goldman Sachs analyst Robert Jones kept his Sell rating on Dentsply Sirona (XRAY) and Patterson Companies (PDCO) while lowering his price target on the former to $43 from $45 and keeping that of the latter at $21. Jones says his Q2 dental survey indicates a "modest softening in consumable purchases and a slightly greater slowdown in equipment spending" reported by U.S. dentists, which puts the guidance of those companies at risk. The survey also revealed that the outlook for dental specialties lik implants and ortho is still more robust, suggesting a mid-single-digit implant market growth rate. The analyst is also positive on Align Technology (ALGN), keeping its Buy rating and raising its price target to $440 from $344 amid the "strong worldwide growth in 'Invisalign' search data" and the continued rollout of iTero in China.
06/05/18
06/05/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Ulta Beauty (ULTA) downgraded to Neutral from Buy at Goldman Sachs with analyst Matthew Fassler saying shares have recently recovered, but sales momentum continues to moderate following a deceleration for six consecutive quarters in same-store-sales. 2. Take-Two (TTWO) downgraded to Market Perform from Outperform at BMO Capital with analyst Gerrick Johnson saying he is "concerned" expectations for the Red Dead Redemption 2 release could be overly optimistic and sees a risk to earnings from a potential slowdown in Grand Theft Auto and NBA 2K. 3. Loxo Oncology (LOXO) downgraded to Market Perform from Strong Buy at IFS Securities. 4. Dentsply Sirona (XRAY) downgraded to Neutral from Buy at Northcoast. 5. First Solar (FSLR) downgraded to Neutral from Buy at BofA/Merrill with analyst Julien Dumoulin-Smith saying she expects a "steep" drop in 2018 Chinese solar deployments following China's recent 2018 Solar PV Power Generation Notice, with further declines in 2019/2020 possible. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/05/18
NRCS
06/05/18
DOWNGRADE
NRCS
Neutral
Dentsply Sirona downgraded to Neutral from Buy at Northcoast
ARMK Aramark
$38.25

-0.07 (-0.18%)

01/24/18
01/24/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Valeant (VRX) initiated with a Sell at Goldman Sachs. 2. trivago (TRVG) initiated with a Hold at SunTrust. 3. Holly Energy (HEP) initiated with a Hold at Jefferies. 4. Aramark (ARMK) reinstated with an Outperform at Credit Suisse. 5. The Medicines Co. (MDCO) reinstated with an Overweight at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/17/18
JPMS
04/17/18
NO CHANGE
Target $50
JPMS
Overweight
Aramark pullback brings buying opportunity, says JPMorgan
JPMorgan analyst Andrew Steinerman believes the recent pullback in shares of Aramark presents a buying opportunity. The company's "self-help" margin expansion opportunity, combined with its "solid track" record on margins should yield "compelling results" this year, Steinerman tells investors in a research note. The analyst points out that the shares have underperformed the market by 14% since the Q1 results on February 6. He keeps an Overweight rating on the name with a $50 price target.
06/19/18
MSCO
06/19/18
NO CHANGE
Target $42
MSCO
Equal Weight
Morgan Stanley cuts Q3 estimates for Aramark on lower baseball attendance
Noting that industry-wide baseball attendance is down 6.7% through June 14, and that attendance has declined by 9.5% at Aramark's 10 stadiums, Morgan Stanley analyst Toni Kaplan lowered her Q3 consolidated organic growth estimate for Aramark to 2.6% from 3.3%. She keeps a $42 price target and Equal Weight rating on Aramark shares.
01/24/18
FBCO
01/24/18
INITIATION
Target $50
FBCO
Outperform
Aramark reinstated with an Outperform at Credit Suisse
Credit Suisse analyst Anjaneya Singh reinstated coverage of Aramark with an Outperform rating and $50 price target after coming off restriction related to the AmeriPride deal.
ODP Office Depot
$2.51

0.035 (1.41%)

10/30/17
JPMS
10/30/17
DOWNGRADE
JPMS
Underweight
Office Depot downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Christopher Horvers downgraded Office Depot (ODP) to Underweight saying the company's sales remain under pressure despite low unemployment and a "solid" economy. Share loss and structural headwinds will only accelerate in the next downturn, Horvers tells investors in a research note. The analyst sees Office Depot as "fighting from behind" against Amazon.com (AMZN) and views the CompuCom acquisition as a "marriage of needs." Horvers does not have a price target for Office Depot shares.
09/05/17
BOFA
09/05/17
INITIATION
Target $6
BOFA
Buy
Office Depot reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Elizabeth Suzuki reinstated Michaels with a Buy and a $6 price target saying shares are inexpensive and the company has been executing on its turnaround.
08/10/17
BOFA
08/10/17
NO CHANGE
Target $6
BOFA
Buy
Office Depot turnaround potential keeps BofA/Merrill at Buy
BofA Merrill Lynch noted that Office Depot's revenue declines in both its commercial and retail segments were worse than the firm had anticipated, but the firm remains positive on the company's ability to grow in adjacent categories and services and expects sales declines will moderate through the year. The firm keeps a Buy rating and $6 price target on Office Depot shares.
DF Dean Foods
$9.45

-0.245 (-2.53%)

05/14/18
DBAB
05/14/18
DOWNGRADE
DBAB
Sell
Dean Foods downgraded to Sell from Hold at Deutsche Bank
05/14/18
05/14/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Dean Foods (DF) downgraded to Sell from Hold at Deutsche Bank analyst Rob Dickerson saying he still sees four fundamental challenges facing the company: continued declines in U.S. dairy milk consumption, its low-margin structured business, increasing vertical category integration by retailers, and what he views as low odds of transformative acquisitions. 2. Owens Corning (OC) downgraded to Market Perform from Outperform at Wells Fargo with analyst Stephen East saying his outlook for Roofing and Composites has weakened and extremely weak year to date 2018 hail/storm activity is likely an incremental headwind to 2H18 Shingle Volumes while inflationary cost pressures are more intense than originally expected. 3. Xerox (XRX) downgraded to Neutral from Overweight at JPMorgan and to Hold from Buy at Cross Research. 4. Jeld-Wen (JELD) downgraded to Neutral from Buy at BofA/Merrill with analyst John Lovallo saying he believes the company will face challenges from the CEO search, Steves & Sons litigation, wood windows, and believes a margin recovery could take longer than expected. 5. Hostess Brands (TWNK) downgraded to Hold from Buy at Deutsche Bank with analyst Rob Dickerson saying he is less certain on the base business' potential margin and profitability progression over the next twelve months following the company's recent earnings report. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/14/18
05/14/18
DOWNGRADE
Target $9

Sell
Dean Foods downgraded to Sell following rally at Deutsche Bank
As previously reported, Deutsche Bank analyst Rob Dickerson downgraded Dean Foods to Sell from Hold after the stock rallied 25% since the company's Q1 earnings report about a week ago, saying he still sees four fundamental challenges facing the company - continued declines in U.S. dairy milk consumption; its low-margin structured business; increasing vertical category integration by retailers; and what he views as low odds of transformative acquisitions. Dickerson raised his price target on Dean Foods shares to $9 from $8.
04/16/18
04/16/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. McDonald's (MCD) downgraded to Equal Weight from Overweight at Stephens with analyst Will Slabaugh saying he believes the mid-single-digit comp growth of recent quarters should not be considered the norm. 2. J.M. Smucker (SJM) downgraded to Underperform from Neutral at Credit Suisse with analyst Robert Moskow saying he believes that while the company has leading brands in two big, growing categories, the dynamic changes in consumer preferences have significantly devalued or commoditized its legacy brands and impaired its competitiveness. 3. Dean Foods (DF) downgraded to Sell from Neutral at Goldman Sachs. 4. Dollar General (DG), Dollar Tree (DLTR), and Big Lots (BIG) were downgraded to Outperform from Strong Buy at Raymond James. 5. Crocs (CROX) downgraded to Negative from Neutral at Susquehanna with analyst Sam Poser saying he believes its wholesale mid-single digit growth may not be sustainable for the next few years despite an expected acceleration of the sandal business. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

IFF

International Flavors

$122.54

-0.98 (-0.79%)

21:34
03/20/19
03/20
21:34
03/20/19
21:34
Upgrade
International Flavors rating change at Goldman Sachs »

International Flavors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

QRVO

Qorvo

$69.15

-0.93 (-1.33%)

21:34
03/20/19
03/20
21:34
03/20/19
21:34
Upgrade
Qorvo rating change at Goldman Sachs »

Qorvo upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

ATI

Allegheny Technologies

$26.02

0.065 (0.25%)

21:34
03/20/19
03/20
21:34
03/20/19
21:34
Upgrade
Allegheny Technologies rating change at Goldman Sachs »

Allegheny Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INAP

Internap

$4.98

0.17 (3.53%)

21:33
03/20/19
03/20
21:33
03/20/19
21:33
Upgrade
Internap rating change at Wells Fargo »

Internap upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRI

Darden

$108.62

-1.79 (-1.62%)

, CAG

Conagra Brands

$22.91

0.095 (0.42%)

20:25
03/20/19
03/20
20:25
03/20/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

DRI

Darden

$108.62

-1.79 (-1.62%)

CAG

Conagra Brands

$22.91

0.095 (0.42%)

CMC

Commercial Metals

$16.06

-0.06 (-0.37%)

GIII

G-III Apparel

$35.09

-0.475 (-1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 21

    Mar

  • 21

    Mar

  • 21

    Mar

HYMTF

Hyundai Motor

$0.00

(0.00%)

19:51
03/20/19
03/20
19:51
03/20/19
19:51
Periodicals
Hyundai shareholders to vote on Elliott Management dividend demand, Reuters says »

Hyundai Motor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVBF

CVB Financial

$21.12

-0.53 (-2.45%)

19:45
03/20/19
03/20
19:45
03/20/19
19:45
Hot Stocks
CVB Financial raises quarterly dividend to 18c from 14c per share »

The dividend will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KAMN

Kaman

$57.84

0.345 (0.60%)

19:24
03/20/19
03/20
19:24
03/20/19
19:24
Periodicals
Kaman exploring sale of distribution segment, Bloomberg says »

Kaman is looking into a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Apr

VALE

Vale

$13.49

-0.21 (-1.53%)

19:19
03/20/19
03/20
19:19
03/20/19
19:19
Hot Stocks
Vale suspends operations at Alegria mine in Mariana complex on preventive basis »

Vale S.A. informs that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

EQH

AXA Equitable

$20.84

-0.565 (-2.64%)

19:12
03/20/19
03/20
19:12
03/20/19
19:12
Syndicate
AXA Equitable 40M share Secondary priced at $20.50 »

JPMorgan, Morgan Stanley…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

OTTW

Ottawa Bancorp

$13.56

-0.14 (-1.02%)

19:02
03/20/19
03/20
19:02
03/20/19
19:02
Hot Stocks
Ottawa Bancorp declares special dividend of 35c per share »

The special dividend will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JAZZ

Jazz Pharmaceuticals

$133.73

-1.74 (-1.28%)

18:57
03/20/19
03/20
18:57
03/20/19
18:57
Hot Stocks
Jazz Pharmaceuticals' Sunosi for excessive daytime sleepiness approved by FDA »

Jazz…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

AYI

Acuity Brands

$123.00

-5.53 (-4.30%)

18:52
03/20/19
03/20
18:52
03/20/19
18:52
Upgrade
Acuity Brands rating change at Goldman Sachs »

Acuity Brands upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Apr

HYAC

Haymaker Acquisition

$11.79

(0.00%)

, OSW

OneSpaWorld

$0.00

(0.00%)

18:47
03/20/19
03/20
18:47
03/20/19
18:47
Hot Stocks
OneSpaWorld says will start trading on Nasdaq March 21 »

OneSpaWorld Holdings…

HYAC

Haymaker Acquisition

$11.79

(0.00%)

OSW

OneSpaWorld

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLHR

Herman Miller

$35.07

-0.85 (-2.37%)

, MU

Micron

$40.08

-0.3 (-0.74%)

18:46
03/20/19
03/20
18:46
03/20/19
18:46
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: …

MLHR

Herman Miller

$35.07

-0.85 (-2.37%)

MU

Micron

$40.08

-0.3 (-0.74%)

WSM

Williams-Sonoma

$56.88

0.09 (0.16%)

SIEN

Sientra

$9.76

0.945 (10.73%)

EB

Eventbrite

$20.09

-0.72 (-3.46%)

GES

Guess

$22.10

-0.41 (-1.82%)

UNIT

Uniti Group

$10.01

0.15 (1.52%)

WEX

Wex

$184.85

-1.465 (-0.79%)

CBMG

Cellular Biomedicine

$18.26

0.38 (2.13%)

FTDR

Frontdoor

$32.10

-2.29 (-6.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 02

    Apr

  • 03

    Apr

  • 28

    May

  • 21

    Mar

  • 21

    Mar

SAGE

Sage Therapeutics

$152.62

-3.46 (-2.22%)

18:39
03/20/19
03/20
18:39
03/20/19
18:39
Hot Stocks
Sage Therapeutics CEO: Postpartum depression is a medical issue »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$174.38

-1.39 (-0.79%)

18:27
03/20/19
03/20
18:27
03/20/19
18:27
Recommendations
Nvidia analyst commentary at Tigress Financial »

Nvidia to overcome…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CURLF

Curaleaf Holdings

$0.00

(0.00%)

, CVS

CVS Health

$56.17

-0.93 (-1.63%)

18:24
03/20/19
03/20
18:24
03/20/19
18:24
Periodicals
CVS to start selling CBD products in partnership with Curaleaf, Bloomberg says »

Curaleaf (CURLF) said…

CURLF

Curaleaf Holdings

$0.00

(0.00%)

CVS

CVS Health

$56.17

-0.93 (-1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

PETQ

PetIQ

$29.87

0.91 (3.14%)

18:23
03/20/19
03/20
18:23
03/20/19
18:23
Hot Stocks
PetIQ CEO: We are totally transparent about our price model »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

T

AT&T

$30.51

-0.19 (-0.62%)

18:21
03/20/19
03/20
18:21
03/20/19
18:21
Periodicals
AT&T CEO: Huawei makes it hard for carriers to shift suppliers, Reuters says »

AT&T CEO Randall…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 24

    Apr

  • 26

    Apr

  • 07

    May

  • 20

    May

SGSOY

SGS SA

$0.00

(0.00%)

18:19
03/20/19
03/20
18:19
03/20/19
18:19
Downgrade
SGS SA rating change at Goldman Sachs »

SGS SA downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLX

Clorox

$155.94

-0.93 (-0.59%)

, RBGLY

Reckitt Benckiser

$0.00

(0.00%)

18:16
03/20/19
03/20
18:16
03/20/19
18:16
Hot Stocks
Clorox files false advertising lawsuit against Reckitt Benckiser »

The Clorox Company (CLX)…

CLX

Clorox

$155.94

-0.93 (-0.59%)

RBGLY

Reckitt Benckiser

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

BA

Boeing

$376.41

2.54 (0.68%)

18:09
03/20/19
03/20
18:09
03/20/19
18:09
Periodicals
Boeing pushes flight test to International Space Station to August, Reuters says »

Boeing has postponed by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 28

    May

CE

Celanese

$101.04

0.08 (0.08%)

18:02
03/20/19
03/20
18:02
03/20/19
18:02
Hot Stocks
Celanese increases acetyl intermeditates prices »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

FTDR

Frontdoor

$32.10

-2.29 (-6.66%)

17:58
03/20/19
03/20
17:58
03/20/19
17:58
Syndicate
Frontdoor 16.73M share Secondary priced at $30.00 »

JPMorgan and Goldman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.